Michaela Levin Email & Phone Number

Salt Lake City, Utah, US

Oxford, Oxfordshire, GB

Lead due diligence and therapeutic asset transactions. Focused portfolio and regulatory strategy to strengthen Exscientia's pipeline by prioritizing high value oncology and rare disease assets, thereby positioning the company for a merger/combination. Source and lead in- and outlicensing opportunities of therapeutic assets in oncology and rare diseases to.

Cambridge, Massachusetts, US

Developed and led business development growth strategies to select for global partners to accelerate path to marketBuilt product strategies and refocused Editas pipeline around hemoglobinopathies and in-vivo to maximize portfolio valueSourced and led due diligence, negotiated multiple term sheets and executed multiple multi-million dollar licenses

New York, New York, US

Sourced and lead in/out-licensing deals, and commercial and academic collaborations. Closed deal value >$150M in rare neurological diseases and epilepsy. Led due diligence teams to evaluate global opportunities.

Led $1.7B acquisition deal of Constellation Pharma by MorphoSys AG (July 2021). Created roadmap of Constellation integration into MorphoSys and led cross-functional teams. Performed search and evaluation toward in- and out-licensing and collaborations focusing on oncology, hematological malignancies and rare diseases. Led cross-functional teams to support.

Managed the Neuroscience / Neurology portfolio of Brigham & Women's Hospital and Radiation Oncology portfolio of Massachusetts General Hospital (therapeutics, biomarkers, diagnostics, medical devices, and research tools); facilitate commercialization of new technologies through start-ups and license deals.Led negotiations of deal terms on license, option.

Identify business development opportunities and potential partnerships and alliances. Develop licensing strategy and negotiate and execute licensing agreements for life science technologies. Assist with clinical strategies.

Philadelphia, PA, US

Assisted in drafting and prosecuting patent applications in the practice areas of biotechnology, pharmaceuticals and a wide range of technologies. Aids in preparing patentability, invalidity, infringement and freedom to operate searches and opinions on US and international inventions.

Cambridge, Massachusetts, US

Commercialized and protected innovative technologies in the life sciences and medical devices for Harvard University's OTD at Harvard Medical School and fostered and managed strategic collaborations with industry partners. Performed strategic, commercial/market, and financial analyses.

Boston, MA, US

In the Rotenberg lab I validated new epileptogenic targets and examined the biophysical properties of hippocampal neurons in epilepsy and traumatic brain injury models. To modulate cortical excitability I used transcranial direct current stimulation (tDCS) in patients suffering from refractory status epileticus and in murine epilepsy models. Specifically.

Charlottesville, VA, US

Summary: Electrophysiology, Patch-Clamp Recordings, Preclinical Testing in Diabetes Mouse Model, Molecular Biology, Immunohistochemistry, Potassium Ion Channels, Inner Ear ResearchResearch Description: In the Holt/Géléoc lab my research focused on identifying the biophysical properties of potassium ion channels in the inner ear. Using molecular biology I.

Jazz and Classical Performances solo and with ensemble, Music lessons in Saxophone, Flute, Clarinet, and Piano, Jazz and Classical Music Theory, Jazz Composition and Arrangement

Charlottesville, VA, US

Immunohistochemistry, Confocal Microscopy, Electron Microscopy, Serotonergic and Dopaminergic Systems in Drosophila and their role in Depression Disorders.

Phd, Neuroscience

Jazz Diploma, Jazz Performance

Ma, Performance And Composition